Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1993 1
1995 1
1997 3
1998 5
1999 1
2000 2
2001 1
2002 5
2003 5
2005 1
2006 1
2007 1
2008 1
2012 4
2014 2
2015 4
2016 2
2017 2
2018 1
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Abuse Potential Study of ALO-02 (Extended-Release Oxycodone Surrounding Sequestered Naltrexone) Compared with Immediate-Release Oxycodone Administered Orally to Nondependent Recreational Opioid Users.
Setnik B, Bass A, Bramson C, Levy-Cooperman N, Malhotra B, Matschke K, Geoffroy P, Sommerville KW, Wolfram G. Setnik B, et al. Among authors: sommerville kw. Pain Med. 2017 Jun 1;18(6):1077-1088. doi: 10.1093/pm/pnw178. Pain Med. 2017. PMID: 27550954 Free PMC article. Clinical Trial.
Intranasal administration of crushed ALO-02 (extended-release oxycodone with sequestered naltrexone): A randomized, controlled abuse-potential study in nondependent recreational opioid users.
Setnik B, Bramson C, Bass A, Levy-Cooperman N, Malhotra B, Matschke K, Sommerville KW, Wolfram G, Geoffroy P. Setnik B, et al. Among authors: sommerville kw. J Clin Pharmacol. 2015 Dec;55(12):1351-61. doi: 10.1002/jcph.552. Epub 2015 Jul 2. J Clin Pharmacol. 2015. PMID: 26011742 Clinical Trial.
A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain.
Arora S, Setnik B, Michael D, Hudson JD, Clemmer R, Meisner P, Pixton GC, Goli V, Sommerville KW. Arora S, et al. Among authors: sommerville kw. J Opioid Manag. 2014 Nov-Dec;10(6):423-36. doi: 10.5055/jom.2014.0239. J Opioid Manag. 2014. PMID: 25531960 Clinical Trial.
A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatment.
Rauck RL, Hale ME, Bass A, Bramson C, Pixton G, Wilson JG, Setnik B, Meisner P, Sommerville KW, Malhotra BK, Wolfram G. Rauck RL, et al. Among authors: sommerville kw. Pain. 2015 Sep;156(9):1660-1669. doi: 10.1097/j.pain.0000000000000230. Pain. 2015. PMID: 25993547 Clinical Trial.
42 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page